Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants
Author(s) -
Mihai PuiaDumitrescu,
Thomas R. Wood,
Bryan A. Comstock,
Janessa B. Law,
Kendell German,
Krystle Perez,
Semsa Gogcu,
Dennis E. Mayock,
Patrick J. Heagerty,
Sandra E. Juul,
Rajan Wadhawan,
Sherry E. Courtney,
Tonya Robinson,
Kaashif A. Ahmad,
Ellen BendelStenzel,
Mariana Baserga,
Edmund F. LaGamma,
L. Corbin Downey,
Raghavendra Rao,
Nancy Fahim,
Andrea Lampland,
Ivan D. Frantz,
Janine Y. Khan,
Michael Weiss,
Maureen Gilmore,
Robin K. Ohls,
Jean Lowe,
Nishant Srinivasan,
Jorge Perez,
Victor McKay
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.1947
Subject(s) - medicine , bronchopulmonary dysplasia , pediatrics , gestational age , prednisolone , retinopathy of prematurity , bayley scales of infant development , dexamethasone , intensive care , gestation , methylprednisolone , intensive care medicine , pregnancy , psychomotor learning , genetics , cognition , psychiatry , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom